Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: Cancer Immunol Immunother. 2015 May 9;64(8):977–987. doi: 10.1007/s00262-015-1706-4

Fig. 5.

Fig. 5

Ad5 NAb titers over time in 6 mCRC patients immunized with Ad5 [E1-, E2b-]-CEA(6D). Titers increased in all patients by week 9 (3 weeks after the last immunization) and then decreased thereafter.